Skip to main content

Table 3 Comparison between the patients and control group regarding hyaluronic acid (HA) ng/ml on visit 1

From: Assessment of hyaluronic acid in COPD patients as a prognostic biomarker

Hyaluronic acid (HA) ng/ml

Groups

Test of sig

Post hoc test

Subgroup 1 (no. = 30)

Subgroup 2 (no. = 30)

Control group (no. = 20)

H

p-value

Visit 1

269.33 ± 40

290 ± 40

14.75 ± 10

46.25

0.000**

P1 = 0.007*

P2 = 0.00**

P3 = 0.00**

  1. P1 subgroup 1 vs subgroup 2, P2 control group vs subgroup 1, P3 control group vs subgroup 2. *P-value < 0.05 is significant, **p-value ≤ 0.001 strong significant, H Kruskal–Wallis test H, no. number